Anticancer drug costs in the United States increase substantially after launch regardless of competition, according to a new study

The researchers who built the program at the Georgia Institute of Technology would like cancer fighters to take it for free, or even just swipe parts of their programming code, so they’ve made it open source

New gene drive targeting a fungal pathogen enables identification of virulence regulators and potential future combination therapies

In recent years, researchers have learned more—largely through 3D atomic structures—about how G protein-coupled receptors are built and thus how they function

Antibiotics work in different ways, but some can attack the very basic process of making new proteins in bacterial cells

Collaborative agreement will focus on researching and developing safer pharmaceutical cannabis-based products and moving these products through clinical trials using FDA guideline

Postnova Analytics announces the launch of the EAF2000—an innovative new simultaneous Electrical and Asymmetrical Flow Field Flow Fractionation (EAF4) system

Researchers have discovered a key difference between the way immune cells attack bacteria and the way antibiotics do

Discovery could lead to new antibacterial agents and drugs to combat toxins

UC San Francisco / UNC Chapel Hill team determines first high-resolution structure of dopamine receptor